Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 420 Records) |
Query Trace: Antidepressants[original query] |
---|
Half a century of research on Attention-Deficit/Hyperactivity Disorder: A scientometric study. Neuroscience and biobehavioral reviews 2022 7 140 104769. Cortese Samuele, Sabé Michel, Chen Chaomei, Perroud Nader, Solmi Mar |
CYP2C19 and CYP2D6 Genotypes and Metabolizer Status Distribution in a Bulgarian Psychiatric Cohort. Journal of personalized medicine 2022 Jul 12 (7): . Ivanov Hristo Y, Grigorova Denitsa, Lauschke Volker M, Velinov Branimir, Stoychev Kaloyan, Kyosovska Gergana, Shopov Pet |
Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study. Pharmaceuticals (Basel, Switzerland) 2022 7 15 (7): . Thiele Liv S, Ishtiak-Ahmed Kazi, Thirstrup Janne P, Agerbo Esben, Lunenburg Carin A T C, Müller Daniel J, Gasse Christia |
A comprehensive approach to predicting weight gain and therapy response in psychopharmacologically treated major depressed patients: A cohort study protocol. PloS one 2022 17 (7): e0271793. Simon Maria S, Barton Barbara B, Glocker Catherine, Musil Richa |
Pharmacogenetics and Pain Treatment with a Focus on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Antidepressants: A Systematic Review. Pharmaceutics 2022 6 14 (6): . Zobdeh Farzin, Eremenko Ivan I, Akan Mikail A, Tarasov Vadim V, Chubarev Vladimir N, Schiöth Helgi B, Mwinyi Jessi |
A Double-Blind Randomized Trial to Investigate Mechanisms of Antidepressant-Related Dysfunctional Arousal in Depressed or Anxious Youth at Familial Risk for Bipolar Disorder. Journal of personalized medicine 2022 6 12 (6): . Honeycutt Duncan C, DelBello Melissa P, Strawn Jeffrey R, Ramsey Laura B, Patino Luis R, Hinman Kyle, Welge Jeffrey, Miklowitz David J, Jo Booil, Blom Thomas J, Bruns Kaitlyn M, Hamill Skoch Sarah K, Starace Nicole, Tallman Maxwell J, Singh Manpreet |
Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials. Neuroscience and biobehavioral reviews 2022 12 144 104965. Arnone Danilo, Omar Omar, Arora Teresa, Östlundh Linda, Ramaraj Reshma, Javaid Syed, Govender Romona Devi, Ali Bassam R, Patrinos George P, Young Allan H, Stip Emmanu |
Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic Study. Metabolites 2022 12 12 (12): . Cusato Jessica, Borghetti Alberto, Teti Elisabetta, Milesi Maurizio, Tettoni Maria Cristina, Bonora Stefano, Trunfio Mattia, D'Avolio Antonio, Compagno Mirko, Di Giambenedetto Simona, Di Perri Giovanni, Calcagno Andr |
Predicting drug-drug and drug-gene interactions in a community pharmacy population. The American journal of managed care 2022 11 28 (11): 566-571. Dowd Daniel, Williams Gabriela, VanDorn Daniel, Clarke Stephen, Krause David S, Botbyl Jeffrey, Saklad Stephen |
Pharmacogenomics in Psychiatry Practice: The Value and the Challenges. International journal of molecular sciences 2022 11 23 (21): . Alchakee Aminah, Ahmed Munazza, Eldohaji Leen, Alhaj Hamid, Saber-Ayad Ma |
A one-year follow-up study of treatment-compliant suicide attempt survivors: relationship of CYP2D6-CYP2C19 and polypharmacy with suicide reattempts. Translational psychiatry 2022 10 12 (1): 451. Peñas-Lledó Eva M, Guillaume Sebastien, de Andrés Fernando, Cortés-Martínez Ana, Dubois Jonathan, Kahn Jean Pierre, Leboyer Marion, Olié Emilie, LLerena Adrián, Courtet Philip |
The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank. Pharmaceuticals (Basel, Switzerland) 2023 9 16 (9): . Win Lee Edwin Wong, Chiara Fabbri, Benjamin Laplace, Danyang Li, Roos van Westrhenen, Cathryn M Lewis, Gavin Stewart Dawe, Allan H You |
Pharmacogenetic Variants Associated with Fluoxetine Pharmacokinetics from a Bioequivalence Study in Healthy Subjects. Journal of personalized medicine 2023 9 13 (9): . Carlos Alejandro Díaz-Tufinio, José Antonio Palma-Aguirre, Vanessa Gonzalez-Covarrubi |
The relationship between antidepressants and breast cancer: evidence from Mendelian randomization. Cancer causes & control : CCC 2023 8 . Dong Niu, Chenchen Li, Xiaoyu Yan, Haoran Qu, Yuling Zhe |
The Value of Pharmacogenomics for White and Indigenous Americans after Kidney Transplantation. Pharmacy (Basel, Switzerland) 2023 8 11 (4): . Alexandra Brady, Suman Misra, Mina Abdelmalek, Adrijana Kekic, Katie Kunze, Elisabeth Lim, Nicholas Jakob, Girish Mour, Mira T Kedd |
Psychopharmacological Medication Use in Frontotemporal Dementia at the Time of Diagnosis: Comparison with Alzheimer's Disease. Journal of Alzheimer's disease : JAD 2023 8 . Kasper Katisko, Johanna Krüger, Helmi Soppela, Päivi Hartikainen, Annakaisa Haapasalo, Anne M Remes, Eino Sol |
Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies. medRxiv : the preprint server for health sciences 2023 7 . Danyang Li, Oliver Pain, Chiara Fabbri, Win Lee Edwin Wong, Chris Wai Hang Lo, Stephan Ripke, Annamaria Cattaneo, Daniel Souery, Mojca Z Dernovsek, Neven Henigsberg, Joanna Hauser, Glyn Lewis, Ole Mors, Nader Perroud, Marcella Rietschel, Rudolf Uher, Wolfgang Maier, Katherine J Aitchison, Bernhard T Baune, Joanna M Biernacka, Guido Bondolfi, Katharina Domschke, Masaki Kato, Yu-Li Liu, Alessandro Serretti, Shih-Jen Tsai, Richard Weinshilboum, , , Andrew M McIntosh, Cathryn M Lew |
Association of systemic medication use with glaucoma and intraocular pressure: the E3 Consortium. Ophthalmology 2023 5 . Joëlle E Vergroesen, Alexander K Schuster, Kelsey V Stuart, Nigus G Asefa, Audrey Cougnard-Grégoire, Cécile Delcourt, Cédric Schweitzer, Patrícia Barreto, Rita Coimbra, Paul J Foster, Robert N Luben, Norbert Pfeiffer, Julia V Stingl, Toralf Kirsten, Franziska G Rauscher, Kerstin Wirkner, Nomdo M Jansonius, Louis Arnould, Catherine P Creuzot-Garcher, Bruno H Stricker, Christina Keskini, Fotis Topouzis, Geir Bertelsen, Anne E Eggen, Mukharram M Bikbov, Jost B Jonas, Caroline C W Klaver, Wishal D Ramdas, Anthony P Khawaja, |
The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy. Genes 2023 5 14 (5): . Milica Radosavljevic, Dubravka Svob Strac, Jasna Jancic, Janko Samardz |
Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study. International journal of clinical pharmacy 2023 5 . Maike Scherf-Clavel, Amelie Frantz, Andreas Eckert, Heike Weber, Stefan Unterecker, Jürgen Deckert, Andreas Reif, Martina Ha |
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants. Clinical pharmacology and therapeutics 2023 4 . Bousman Chad A, Stevenson James M, Ramsey Laura B, Sangkuhl Katrin, Hicks J Kevin, Strawn Jeffrey R, Singh Ajeet B, Ruaño Gualberto, Mueller Daniel J, Tsermpini Evangelia Eirini, Brown Jacob T, Bell Gillian C, Leeder J Steven, Gaedigk Andrea, Scott Stuart A, Klein Teri E, Caudle Kelly E, Bishop Jeffrey |
The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression. Expert review of molecular diagnostics 2023 4 1-14. Nikolac Perkovic Matea, Gredicak Martin, Sagud Marina, Nedic Erjavec Gordana, Uzun Suzana, Pivac Ne |
The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses. Frontiers in pharmacology 2023 3 14 1080117. Kee Ping Siu, Maggo Simran D S, Kennedy Martin A, Chin Paul K |
[The relationship of cytochrome P450 isoforms with the efficacy and safety of antipsychotic and antidepressant therapy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2023 11 123 (11): 40-46. S P Bairamova, O V Pavlova, S V Shport, O I Gurina, K A Pavl |
Risk factors associated with newly diagnosed attention-deficit/hyperactivity disorder in adults: a retrospective case-control study. BMC psychiatry 2023 11 23 (1): 870. Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Rebecca Bungay, Emmanuelle Arpin, Annie Guerin, Ann Childre |
Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study. Canadian journal of psychiatry. Revue canadienne de psychiatrie 2023 10 7067437231203433. Farhana Islam, Leen Magarbeh, Samar S M Elsheikh, Stefan Kloiber, Caroline W Espinola, Venkat Bhat, Benicio N Frey, Roumen Milev, Claudio N Soares, Sagar V Parikh, Franca Placenza, Stefanie Hassel, Valerie H Taylor, Francesco Leri, Pierre Blier, Rudolf Uher, Faranak Farzan, Raymond W Lam, Gustavo Turecki, Jane A Foster, Susan Rotzinger, Sidney H Kennedy, Daniel J Müll |
Prenatal serotonin reuptake inhibitor antidepressant exposure, SLC6A4 genetic variations, and cortisol activity in 6-year-old children of depressed mothers: A cohort study. Developmental psychobiology 2023 10 65 (7): e22425. Enav Z Zusman, Cecil M Y Chau, Jeffrey N Bone, Kaia Hookenson, Ursula Brain, Melissa B Glier, Ruth E Grunau, Joanne Weinberg, Angela M Devlin, Tim F Oberland |
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 Study. Clinical pharmacology and therapeutics 2023 1 . Magarbeh Leen, Hassel Claudia, Choi Maximilian, Islam Farhana, Marshe Victoria S, Zai Clement C, Zuberi Rayyan, Gammal Roseann S, Men Xiaoyu, Scherf-Clavel Maike, Enko Dietmar, Frey Benicio N, Milev Roumen, Soares Claudio N, Parikh Sagar V, Placenza Franca, Strother Stephen C, Hassel Stefanie, Taylor Valerie H, Leri Francesco, Blier Pierre, Farzan Faranak, Lam Raymond W, Turecki Gustavo, Foster Jane A, Rotzinger Susan, Kloiber Stefan, Kennedy James L, Kennedy Sidney H, Bousman Chad A, Müller Daniel |
Investigating genetic variants for treatment response to selective serotonin reuptake inhibitors in syndromal factors and side effects among patients with depression in Taiwanese Han population. The pharmacogenomics journal 2023 1 . Huang Shiau-Shian, Chen Yi-Ting, Su Mei-Hsin, Tsai Shih-Jen, Chen Hsi-Han, Yang Albert C, Liu Yu-Li, Kuo Po-Hs |
Phosphoproteomics implicates glutamatergic and dopaminergic signalling in the antidepressant-like properties of the iron chelator deferiprone. Neuropharmacology 2024 1 109837. Volkan Uzungil, Sandra Luza, Carlos M Opazo, Isaline Mees, Shanshan Li, Ching-Seng Ang, Nicholas A Williamson, Ashley I Bush, Anthony J Hannan, Thibault Reno |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: